Journalists KP suggest that the singer treat nanovaccines ICT-107, clinical trials which recently successfully concluded in Los Angeles. Half of the study participants had lived longer than 5 years after the discovery they glioblastoma (such as tumors, as Zhanna Friske). This is a good result, considering that when other treatments such people live an average of 15 months after diagnosis. Although, experts note that such drugs are present in Russia. They are applied in our country, but help a very small number of patients: about one in ten.